Ligand Design of 5,5'-Diphenylimidazolidine-2,4-dione Analogues as A New Class of Potent Inhibitors of Fatty Acid Amide Hydrolase

새로운 Fatty Acid Amide Hydrolase 저해제로서 5,5'-Diphenylimidazolidine-2,4-dione 유도체의 리간드 설계

  • Cho, Jong-Un (Division of Applied Biologies and Chemistry, College of Agriculture and Life Science, Chungnam National University) ;
  • Soung, Min-Gyu (Division of Applied Biologies and Chemistry, College of Agriculture and Life Science, Chungnam National University) ;
  • Sung, Nack-Do (Division of Applied Biologies and Chemistry, College of Agriculture and Life Science, Chungnam National University)
  • 조종운 (충남대학교 농업생명과학대학 응용생물화학부) ;
  • 성민규 (충남대학교 농업생명과학대학 응용생물화학부) ;
  • 성낙도 (충남대학교 농업생명과학대학 응용생물화학부)
  • Published : 2008.06.30

Abstract

3D-QSARs (3 dimensional quantitative structrue-activity relationships) on the inhibition activities of 3-substituted-5,5'-diphenylimidazolidine-2,4-dione derivatives (1-22) against FAAH (fatty acid amide hydrolase) were studied quantitatively using CoMFA (comparative molecular field analysis) and CoMSIA (comparative molecular similarity indice analysis) methods. The statistical results of the CoMFA 1A and CoMSIA 2F model are better predictability and fitness. And also, the designed X=I, Y=$N_{2}^{+}$-substituent (P1: $Pred.pI_{50}$=6.55), according to the contour maps with information of the two models, showed the most inhibition activity against FAAH.

3-치환된 5,5'-diphenylimidazolidine-2,4-dione 유도체(1-22)들의 fatty acid amide hydrolase (FAAH) 저해활성에 관한 3차원적인 정량적 구조와 활성과의 관계(3D-QSARs)를 비교 분자장 분석(CoMFA)과 비교분자 유사성 지수분석(CoMFA) 방법으로 각각 검토하였다. CoMFA A1 모델과 CoMSIA 2F 모델 모두 상관성과 예측성이 양호하였다. 두 모델의 정보에 의한 등고도에 따라 설계된 X=I, Y=$N_2{^+}$-치환체(P1: $Pred.pI_{50}$=6.55)는 FAAH에 대하여 가장 높은 저해활성을 나타내었다.

Keywords

References

  1. Bracey, M. H., Hanson, M. A., Masuda, K. R., Stevens, R. C. and Cravatt, B. F. (2002) Structural adaptations in a Membrane Enzyme that Terminates Endocannabinoid Signaling. Science, 298, 1793-1796 https://doi.org/10.1126/science.1076535
  2. Giang, D. K. and Cravatt, B. F. (1997) Molecular characterization of human and mouse fatty acid amide hydrolases. Proc. Natl. Acad. Sci., U.S.A. 94, 2238-2242 https://doi.org/10.1073/pnas.94.6.2238
  3. Natsuo U., Robyn A. P., Shozo Y. and Dale, G. D. (2000) The fatty acid amide hydrolase (FAAH). Chem. Physics Lipids, 108, 107-121 https://doi.org/10.1016/S0009-3084(00)00190-0
  4. Rodriguez, F., F., Navarro, M., Gomez, R., Escuredo, L., Nava, F., Fu, J., Murillo- Rodriguez, E., Giuffrida, A., LoVerme, J., Gaetani, S., Kathuria, S., Gall, C. and Piomelli, D. (2001) An Anorexic Lipid Mediator Regulated by Feeding. Nature, 414, 209-212 https://doi.org/10.1038/35102582
  5. Goparaju, S. K., Ueda, N., Taniguchi, K. and Yamamoto, S. (1999) Enzymes of Porcine Brain Hydrolyzing 2- arachidomoylglycerol, an Endogenous Ligand of Cannabinoid Receptors. Biochem. Pharmacol. 57, 417-423 https://doi.org/10.1016/S0006-2952(98)00314-1
  6. Rice, A. S., Farquhar-Smith, W. P. and Nagy, I. (2002) Endocannabinoids and Pain Spinal and Peripheral Analgesia Inflammation and Neuropathy. Prostaglandins Leukotrienes Essent. Fatty Acids, 66, 243-256 https://doi.org/10.1054/plef.2001.0362
  7. Kathuria, S., Gaetani, S., Fagley, D., Valino, F., Duranti, A., Tontini, A., Mor, A., Tarzia, G., La Rana, G., Calignano, A., Giustino, A., Tattoli, M., Palmery, M., Cuomo, V. and Piomelli, D. (2003) Modulation of Anxiety Through Blockade of Anandamide Hydrolysis. Nat. Med., 9, 76-81 https://doi.org/10.1038/nm803
  8. Maccaronne, M. and Finazzi-Agro, A. (2004) Anandamide Hydrolase: A Guardian Angel of Human Reproduction. Trends Pharmacol. Sci. 25, 353-357 https://doi.org/10.1016/j.tips.2004.05.002
  9. Cravatt, B. F., Lerner, R. A. and Boger, D. L. (1996) Structure determination of an endogenous sleep-inducing lipid, cis-9- octadecenamide (oleamide): A synthetic approach to the chemical analysis of trace quantities of a natural product J. Am. Chem. Soc., 118, 580-590 https://doi.org/10.1021/ja9532345
  10. Boger, D. L., Henriksen, S. J. and Cravatt, B. F. (1998) Oleamide: an endogenous sleep-inducing lipid and prototypical member of a new class of biological signaling molecules. Curr. Pharm. Des. 4, 303-314
  11. Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A. and Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 1946-1949 https://doi.org/10.1126/science.1470919
  12. Bisogno, T., Di Marzo, V., De Petrocellis, L., Melck, D. and Martin, B. R. (1999) Cannabimimetic fatty acid derivatives: the anandamide family and other endocan- nabinoids. Curr. Med. Chem. 6, 721-744
  13. Schmid, H. H., Schmid, P. C. and Natarajan, V. (1996) The Nacylation- phosphodiesterase pathway and cell signalling. Chem. Phys. Lipids 80, 133-142 https://doi.org/10.1016/0009-3084(96)02554-6
  14. Huitron-Resendiz, S., Gombart, L., Cravatt, B. F. and Henriksen, S. J. (2001) Effect of Oleamide on Sleep and Its Relationship to Blood Pressure, Body Temperature, and Locomotor Activity in Rats. Exp. Neurol., 172, 235-243 https://doi.org/10.1006/exnr.2001.7792
  15. Di Marzo, V., Bisogno, T., De Petrocellis, L., Melck, D. and Martin, B. R. (1999) Cannabimimetic fatty acid derivatives: The anandamide family and other 'endocannabinoids'. Curr. Med. Chem. 6, 721-744
  16. Wu Du, Christophe, H., Heng C., Hwang, I. and Boger, D. L. (2005) Herterocyclic sulfoxide and sulfone inhibitors of fatty acid amide hydrolase. Bioorg. Med. Chem. Lett. 15, 103-106 https://doi.org/10.1016/j.bmcl.2004.10.025
  17. Carl, R. L., Arthur, C. R. and Alexander, F. H. (2004) Marijuana and cannabinoid regulation of brain revard circuits. British J. Pharm., 143, 227-234 https://doi.org/10.1038/sj.bjp.0705931
  18. Di Marzo, V. and Fontana, A. (1995) Anandamide, an endogenous cannabinomimetic eicosanoid: Killing two birds with one stone, Prostaglandins Leukot, Essent. Fatty acids, 53, 1-11 https://doi.org/10.1016/0952-3278(95)90077-2
  19. Tiziana, B., Maria, G. C., Bijali, S., Anu, M., Paolo, U., Alberto, M., Giovanni, A., Carmela, S., Billy, M., Raj, R. and Vincenzo, D. M. (2006) Development of the first potent and specific inhibitors of endocannabinoid biosynthesis. Biochimica et Biophysica Acta 1761, 205-212 https://doi.org/10.1016/j.bbalip.2005.12.009
  20. Pazos, M. R., Nunez, E., Benito, C., Tolon, R. M. and Romero, J. (2004) Role of the endocannabinoid system in Alzheimer's disease: New perspectives. Life Sciences, 75, 1907-1915 https://doi.org/10.1016/j.lfs.2004.03.026
  21. Benito, C., Nunez, E., Tolon, R. M., Carrier, E. J., Rabano, A., Hillard, C. J. and Romero, J. (2003) Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains. J. Neuroscience, 23, 11135-11141
  22. Giulio, G. M., Nicola, F., Gerhard, K. E. S., Wolfgang, P., Fabio ,C., Jacques, H. P., Johan, W. and Didier, M. L. (2006) Substituted 2-Thioxoimidazolidin-4-ones and Imidazolidine-2,4- diones as Fatty Acid Amide Hydrolase Inhibitors templates. J. Med. Chem., 49, 417-425 https://doi.org/10.1021/jm050977k
  23. Purcell, W. P. and Singer, J. A. (1967) A brief review and table of semiempirical parameters used in the Hückel molecular orbital method. J. Chem. Eng. Data. 122, 235-246
  24. Marshall, G. R., Barry, C. D., Bosshard, H. E., Dammkoehler, R. A. and Dunn, D. A. (1979) In Computer-assisted drug design: The conformational parameter in drug design; active analog approach. (ed. Olsen, E. C. and Christoffersen, R. E.), American Chemical Society, Washington, D.C., pp. 205-226
  25. Clark, M., Cramer III, R. D., Jones, D. M., Patterson, D. E. and Simeroth, P. E. (1990) Comparative molecular field analysis (CoMFA). 2. Toward its use with 3D-structural databases, Tetrahedron Comput. Methodol., 3, 47-59 https://doi.org/10.1016/0898-5529(90)90120-W
  26. Cramer III, R. D., Bunce, J. D. and Patterson, D. E. (1988) Cross-validation, Bootstrapping, and partial least squares compared with multiple regression in conventional QSAR studies. Quant. Struct. Act. Relat. 7, 18-25 https://doi.org/10.1002/qsar.19880070105